Related Articles
-
Jun 16, 2009 1Alternative Medicine Find Wider Acceptance by Doctors, Insurers, and Hospitals, Yet They “Lack Value”
“Alternative medicine has become mainstream,” according to Associated Press medical writer Marilynn Marchione. “Consumer spending on it in some cases rivals that of traditional healthcare.” But after stating that major hospitals and clinics increasingly offer complementary and alternative me...
-
Feb 24, 2009 0
This Is Not Science
The headlines were uniformly negative—“Vitamins Are Useless!” An “observational” study at Fred Hutchinson Cancer Research Center in Seattle looked at over 161,000 post-menopausal women, ages 50-79. Of the multivitamin supplements taken, none were counted if they were above tiny “reco...
-
Oct 31, 2018 3
A Message From Suzanne Somers About BHRT
Take Action! Read More ...
-
Oct 25, 2016 0CDC Corruption: Scientists on the Inside Slam the Agency
More evidence of extensive crony ties. Action Alert! Recently we’ve reported on the crony ties between top US Centers for Disease Control and Prevention (CDC) officials and beverage giant Coca-Cola. New evidence suggests that the cronyism at the CDC goes far deeper. A group calling itself CDC Scie...
-
Jun 22, 2010 33
Playing Monopoly With Our Health
The American Dietetic Association (ADA) wants to create a monopoly on state nutritional licensure. This organization—which lists among its corporate sponsors soft drink giants Coca-Cola and PepsiCo, cereal manufacturers General Mills and Kellogg's, candy maker Mars, and Unilever, the multinational...
-
Jul 12, 2010 3
A Medical Maverick’s Fate
The attempt to wipe Andrew Wakefield, MD from the face of the medical community for honestly reporting his findings trying to help his patients (more…)...
-
Aug 5, 2014 31
Insurance Company Drug Managers Now Deciding What’s Medically “Necessary”
Compounded medications aren’t being covered—which means FDA-approved drugs will own the marketplace. Action Alert! (more…)...
-
Feb 16, 2016 16FDA Attacks Brain Health Supplements
We think this is to pave the way for a new blockbuster drug. Action Alert! In October we told you about a potential new blockbuster drug for Alzheimer’s from drug giant Eli Lilly. Solanezumab is in the third and final phase of FDA drug trials, and if approved, could bring in at least $7.6 billion ...
-
Dec 17, 2013 55
To Silence Political Dissent, IRS Issues New Rule Censoring Our Free Speech
ANH-USA could be targeted—along with your right to political representation. Action Alert! (more…)...
-
Jun 10, 2014 32Mumps Vaccine Proves Ineffective
But instead of acknowledging the vaccine’s problems, the CDC and mainstream media blame people who don’t vaccinate. Action Alert! (more…)...
Leave a Reply